Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs T2 Biosystems, Inc. (TTOO)

Advanced Biomed Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $3.1M — 2.1× the size. T2 Biosystems, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −559.5%) and the lower return on invested capital (−33.4% vs 0.00%). Across the 11 metrics below, Advanced Biomed Inc. leads on 8 and T2 Biosystems, Inc. on 3.

Valuation

Metric ADVB TTOO Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m n/m 4.24
P/B 0.20 n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales n/m 6.26 5.18
Earnings yield 300.76% 0.00% (1.50%)
Free cash flow yield (185.35%) 0.00% 0.00%

Profitability

Metric ADVB TTOO Diagnostics & Research median
Gross margin — (76.76%) 48.32%
Operating margin 0.00% (542.59%) (5.68%)
Net margin 0.00% (559.52%) (4.10%)
Free cash flow margin 0.00% (476.64%) 0.00%
Return on equity 84.77% 277.61% 0.00%
Return on assets 36.47% (140.00%) (6.05%)
Return on invested capital (33.43%) 0.00% 0.00%

Growth

Metric ADVB TTOO Diagnostics & Research median
Revenue growth (TTM) — (30.19%) 8.99%
EPS growth (last fiscal year) 266.56% 98.44% 20.36%
Revenue growth, 5-year CAGR — (7.29%) 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB TTOO Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 9.33 0.40 2.27
Net debt to EBITDA 0.06 0.32 0.68

Dividend

Metric ADVB TTOO Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB TTOO Diagnostics & Research median
Market cap 3.14m 6.48m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack